Cargando…
Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders
OBJECTIVE: Transdermal testosterone has been used in different doses and in different stimulation protocols in poor responders. The aim of the present study is to compare the luteal estradiol/GnRH antagonists protocol versus long GnRH agonists in poor responder patients according to the Bologna crit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brazilian Society of Assisted Reproduction
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501741/ https://www.ncbi.nlm.nih.gov/pubmed/30614665 http://dx.doi.org/10.5935/1518-0557.20180090 |
_version_ | 1783416150810427392 |
---|---|
author | Fàbregues, Francesc Solernou, Roser Ferreri, Janisse Guimerá, Marta Peralta, Sara Casals, Gemma Peñarrubia, Joana Creus, Montserrat Manau, Dolors |
author_facet | Fàbregues, Francesc Solernou, Roser Ferreri, Janisse Guimerá, Marta Peralta, Sara Casals, Gemma Peñarrubia, Joana Creus, Montserrat Manau, Dolors |
author_sort | Fàbregues, Francesc |
collection | PubMed |
description | OBJECTIVE: Transdermal testosterone has been used in different doses and in different stimulation protocols in poor responders. The aim of the present study is to compare the luteal estradiol/GnRH antagonists protocol versus long GnRH agonists in poor responder patients according to the Bologna criteria, in which transdermal testosterone has been used prior to the stimulation with gonadotropins. METHODS: In this retrospective analysis, a total of 141 poor responder patients according to the Bologna criteria were recruited. All patients were treated with transdermal testosterone preceding ovarian stimulation with gonadotropins during 5 days. In 53 patients we used the conventional antagonist protocol (Group 1). In 88 patients (GrH pituitary suppression was achieved by leuprolide acetate according to the conventional long protocol (Group 2). We analyzed the ovarian stimulation parameters and IVF outcomes. RESULTS: Comparing groups 1 and 2, there were no significant differences between cancellation rates and number of oocytes retrieved. However the total gonadotropin dose used and the mean length of stimulation were significantly lower in group 1 when compared to group 2. There were no significant differences in pregnancy outcomes; however, there was a slight increase in the implantation rate in group 1 vis-a-vis group 2, although statistical significance was not achieved. CONCLUSION: TT in poor responder patients can be effective both with the conventional agonist's long protocol and with the conventional antagonist's protocol. However, short regimes with previous estradiol antagonists in the luteal phase facilitate ovarian stimulation by shortening the days of treatment and the consumption of gonadotropins |
format | Online Article Text |
id | pubmed-6501741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Brazilian Society of Assisted Reproduction |
record_format | MEDLINE/PubMed |
spelling | pubmed-65017412019-05-20 Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders Fàbregues, Francesc Solernou, Roser Ferreri, Janisse Guimerá, Marta Peralta, Sara Casals, Gemma Peñarrubia, Joana Creus, Montserrat Manau, Dolors JBRA Assist Reprod Original Article OBJECTIVE: Transdermal testosterone has been used in different doses and in different stimulation protocols in poor responders. The aim of the present study is to compare the luteal estradiol/GnRH antagonists protocol versus long GnRH agonists in poor responder patients according to the Bologna criteria, in which transdermal testosterone has been used prior to the stimulation with gonadotropins. METHODS: In this retrospective analysis, a total of 141 poor responder patients according to the Bologna criteria were recruited. All patients were treated with transdermal testosterone preceding ovarian stimulation with gonadotropins during 5 days. In 53 patients we used the conventional antagonist protocol (Group 1). In 88 patients (GrH pituitary suppression was achieved by leuprolide acetate according to the conventional long protocol (Group 2). We analyzed the ovarian stimulation parameters and IVF outcomes. RESULTS: Comparing groups 1 and 2, there were no significant differences between cancellation rates and number of oocytes retrieved. However the total gonadotropin dose used and the mean length of stimulation were significantly lower in group 1 when compared to group 2. There were no significant differences in pregnancy outcomes; however, there was a slight increase in the implantation rate in group 1 vis-a-vis group 2, although statistical significance was not achieved. CONCLUSION: TT in poor responder patients can be effective both with the conventional agonist's long protocol and with the conventional antagonist's protocol. However, short regimes with previous estradiol antagonists in the luteal phase facilitate ovarian stimulation by shortening the days of treatment and the consumption of gonadotropins Brazilian Society of Assisted Reproduction 2019 /pmc/articles/PMC6501741/ /pubmed/30614665 http://dx.doi.org/10.5935/1518-0557.20180090 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Fàbregues, Francesc Solernou, Roser Ferreri, Janisse Guimerá, Marta Peralta, Sara Casals, Gemma Peñarrubia, Joana Creus, Montserrat Manau, Dolors Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders |
title | Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders |
title_full | Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders |
title_fullStr | Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders |
title_full_unstemmed | Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders |
title_short | Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders |
title_sort | comparison of gnrh agonist versus luteal estradiol
gnrh antagonist protocol using transdermal testosterone in poor
responders |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501741/ https://www.ncbi.nlm.nih.gov/pubmed/30614665 http://dx.doi.org/10.5935/1518-0557.20180090 |
work_keys_str_mv | AT fabreguesfrancesc comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT solernouroser comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT ferrerijanisse comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT guimeramarta comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT peraltasara comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT casalsgemma comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT penarrubiajoana comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT creusmontserrat comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders AT manaudolors comparisonofgnrhagonistversuslutealestradiolgnrhantagonistprotocolusingtransdermaltestosteroneinpoorresponders |